Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

998
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
998
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.7K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

649
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
649
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"We sometimes stress our own wives": perspectives on maternal mental health and emotional support among mothers, fathers, nurses, and community health workers in Western Kenya.

BMC pregnancy and childbirth·2026
Same author

The value of extra-diaphragmatic inspiratory muscle surface electromyography during postural control tasks in patients with chronic obstructive pulmonary disease.

Respiratory medicine·2025
Same author

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.

Trials·2021
Same author

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.

Trials·2021
Same author

Early integrated palliative care in chronic heart failure and chronic obstructive pulmonary disease: protocol of a feasibility before-after intervention study.

Pilot and feasibility studies·2019
Same author

Thrombosis of an Arteria Lusoria with Secondary Subclavian Steal Syndrome and Swallowing Difficulties.

Journal of the Belgian Society of Radiology·2018
Same journal

The upper airway in obstructive sleep apnoea: state of the art.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Cough biomarkers for diagnosis and monitoring of respiratory disease: a systematic review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

The importance of symptoms in bronchiectasis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

WABIP/AABIP statement on therapeutic indications of medical thoracoscopy for benign pleural disease.

European respiratory review : an official journal of the European Respiratory Society·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

3.1K

Mucoactive therapy in COPD.

M Decramer1, W Janssens

  • 1Respiratory Division, University of Leuven, Herestraat 49, Leuven, Belgium. Marc.Decramer@uzleuven.be

European Respiratory Review : an Official Journal of the European Respiratory Society
|October 20, 2010
PubMed
Summary
This summary is machine-generated.

Mucoactive drugs, including N-acetylcysteine and carbocysteine, significantly reduce exacerbations and disability days in chronic obstructive pulmonary disease (COPD) patients. These mucolytics are well-tolerated and may be considered for long-term COPD management.

More Related Videos

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.7K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K

Related Experiment Videos

Last Updated: Apr 23, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

3.1K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.7K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Mucus hypersecretion is linked to increased chronic obstructive pulmonary disease (COPD) severity, hospitalizations, and mortality.
  • Mucoactive drugs aim to improve mucus clearance and reduce airway obstruction.

Observation:

  • Meta-analyses of mucoactive drugs (N-acetylcysteine, carbocysteine) in chronic bronchitis and COPD show reduced exacerbations and disability days.
  • Adverse events were less frequent with mucolytics compared to placebo.

Findings:

  • N-acetylcysteine reduced exacerbations in COPD patients not on inhaled corticosteroids.
  • High-dose carbocysteine significantly reduced COPD exacerbations and improved quality of life.

Implications:

  • Mucoactive agents demonstrate potential benefits in managing COPD symptoms and disease progression.
  • Further research is needed to elucidate mechanisms and identify specific patient phenotypes that benefit most from mucoactive therapy.